What nursing considerations should be taken before and during a heparin infusion for a patient?

Nursing Considerations for Heparin Infusion

Before initiating heparin, verify the correct vial strength to prevent fatal medication errors, obtain baseline platelet count and coagulation studies (aPTT), assess bleeding risk factors, and ensure the patient is not pregnant or an infant requiring the preservative-free formulation. 1

Pre-Administration Assessment

Critical Safety Check

• Confirm correct heparin concentration - Fatal medication errors have occurred when standard heparin vials were confused with catheter lock flush vials, particularly in pediatric patients 1
• Verify the ordered dose matches the vial strength being administered

Baseline Laboratory Values

• Obtain platelet count - Essential for monitoring heparin-induced thrombocytopenia (HIT) 2
• Measure baseline aPTT or ACT for therapeutic monitoring 1
• Check hematocrit and assess for occult blood in stool 1

Patient-Specific Considerations

High-Risk Populations:

• Neonates/Infants: Use only preservative-free formulation - benzyl alcohol in standard preparations causes fatal "gasping syndrome" with neurological deterioration, seizures, intracranial hemorrhage, and cardiovascular collapse 1
• Elderly patients (>60 years): Higher bleeding risk, particularly in women; may require lower doses 1
• Renal insufficiency: Consider dose adjustments; if severe renal failure develops and patient needs alternative anticoagulation, argatroban is preferred over other agents 2

Bleeding Risk Assessment

Evaluate for conditions increasing hemorrhage risk 1:

• Active bleeding or recent surgery
• Severe hypertension
• Gastrointestinal ulceration
• Hemophilia or thrombocytopenia
• Recent stroke or intracranial surgery

During Infusion Monitoring

Platelet Count Surveillance for HIT

For patients with HIT risk >1%: Monitor platelet count every 2-3 days from day 4 to day 14 (or until heparin stopped) 2

For patients with HIT risk <1%: Platelet monitoring not required 2

Critical warning signs of HIT:

• Platelet count drop ≥50% from baseline
• New thrombosis despite anticoagulation
• Skin necrosis at injection sites
• Acute systemic reactions after bolus

If HIT suspected: Stop heparin immediately and switch to non-heparin anticoagulant (argatroban, lepirudin, or danaparoid) 2

Therapeutic Monitoring

• aPTT testing: Blood coagulation tests guide full-dose heparin therapy 1
• Frequency varies by protocol but typically every 4-6 hours initially until therapeutic, then daily
• Nurse-driven protocols using standardized algorithms improve time to therapeutic range (mean 15.2 hours vs 18.6 hours with traditional care) 3

Ongoing Assessments

• Bleeding surveillance 1:

  • Monitor all puncture sites, wounds, and mucous membranes
  • Check for hematuria, hematemesis, melena, or unusual bruising
  • Assess neurological status for signs of intracranial bleeding
  • Periodically check hematocrit and occult blood in stool

• Infusion site monitoring:

  • Assess IV site for patency, phlebitis, and extravasation
  • Document site condition regularly

Key Nursing Responsibilities

Documentation

• Record all aPTT/ACT results and corresponding heparin dose adjustments
• Document platelet counts and trending
• Note any bleeding episodes or complications

Patient Education

• Explain bleeding precautions (soft toothbrush, electric razor, avoid contact sports)
• Instruct to report any unusual bleeding, bruising, or dark stools immediately
• Discuss fall prevention strategies

Emergency Preparedness

Overdose management 1:

• Protamine sulfate reverses heparin (1 mg protamine neutralizes ~100 units heparin)
• Maximum 50 mg protamine per 10-minute period
• Have resuscitation equipment available - protamine can cause anaphylactoid reactions

Common Pitfalls to Avoid

1. Medication errors: Always perform independent double-check of concentration before administration
2. Delayed HIT recognition: Don't assume thrombocytopenia is due to other causes in days 4-14 of therapy
3. Premature warfarin initiation: If transitioning to warfarin, wait until platelets recover (usually ≥150 × 10⁹/L) if HIT suspected 2
4. Using preserved formulations in neonates: This is potentially fatal 1
5. Inadequate bleeding assessment: Hemorrhage is the chief complication - maintain high index of suspicion 1